Condition
Chronic Kidney Disease Stage 5 clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Chronic Kidney Disease Stage 5 clinical trials that are recruiting, at sites in 4 countries (most in United States (2), Egypt (1), Canada (1)). By phase: Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Chronic Kidney Disease Stage 5 clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Home-based exercise to boost fitness for people waiting for a kidney transplant | — | Philadelphia, Pennsylvania | Recruiting | Mar 3, 2026 |
| Evaluating the effects of dapagliflozin on kidney function in advanced chronic kidney disease | Phase 3 | Cairo | Recruiting | May 21, 2025 |
| Improving decision-making for older adults with advanced kidney disease | — | Hong Kong | Recruiting | Jan 29, 2025 |
| BZLF1 peptide vaccine with QS-21 to prevent EBV-related cancers in patients awaiting organ transplants | Phase 1 | Columbus, Ohio | Recruiting | Dec 18, 2024 |
| Telemonitoring platform for high-risk chronic kidney disease patients | — | Winnipeg, Manitoba and 4 other locations | Recruiting | Feb 14, 2023 |
All recruiting trials (5)
-
Home-based exercise to boost fitness for people waiting for a kidney transplant
This study tests whether a 12-week, home-based exercise program plus a wearable activity tracker helps adults on the kidney transplant waiting list increase daily activity and improve physical function.
-
Evaluating the effects of dapagliflozin on kidney function in advanced chronic kidney disease
This study is testing if the medication dapagliflozin can help slow down kidney problems and lower the risk of heart or kidney-related deaths in adults with advanced chronic kidney disease.
-
Improving decision-making for older adults with advanced kidney disease
This study is testing a new way to help older adults with advanced kidney disease make better decisions about their treatment by improving communication with their doctors.
-
BZLF1 peptide vaccine with QS-21 to prevent EBV-related cancers in patients awaiting organ transplants
This early-phase trial tests a BZLF1-based vaccine (OSU-2131) with QS-21 to see if it is safe and can help prevent EBV infection and related cancers in healthy people and in patients waiting for a solid organ transplant.
-
Telemonitoring platform for high-risk chronic kidney disease patients
This study is testing if a new virtual care platform can help people with advanced kidney disease stay healthier and avoid trips to the emergency room or hospital.
Related topics
Quick answers
How many Chronic Kidney Disease Stage 5 clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), Egypt (1 trial), Canada (1 trial), Hong Kong (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.